4-52076798-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145263.4(SPATA18):c.778C>T(p.Pro260Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000775 in 1,613,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145263.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATA18 | NM_145263.4 | c.778C>T | p.Pro260Ser | missense_variant | 7/13 | ENST00000295213.9 | NP_660306.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA18 | ENST00000295213.9 | c.778C>T | p.Pro260Ser | missense_variant | 7/13 | 1 | NM_145263.4 | ENSP00000295213.4 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152254Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000925 AC: 23AN: 248538Hom.: 0 AF XY: 0.0000520 AC XY: 7AN XY: 134594
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1461572Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727048
GnomAD4 genome AF: 0.000387 AC: 59AN: 152372Hom.: 0 Cov.: 31 AF XY: 0.000322 AC XY: 24AN XY: 74516
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | The c.778C>T (p.P260S) alteration is located in exon 7 (coding exon 7) of the SPATA18 gene. This alteration results from a C to T substitution at nucleotide position 778, causing the proline (P) at amino acid position 260 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at